6505--Specialty Pharmaceutical Lenalidomide FAR Part 8 FSS - LPTA
Veterans Affairs · 244-NETWORK CONTRACT OFFICE 4 (36C244)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C24426Q0216 in this department, oldest first.
- Feb 12, 2026 · this noticeAward NoticeEXELAN PHARMACEUTICALS INC · $249K
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
What the notice says
Specialty Pharmaceutical Lenalidomide Coatesville 0001 273.00 EA __________________ __________________ Lenalidomide 5MG CAP, ORAL Contract Period: Base POP Begin: 02-06-2026 POP End: 02-05-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals 0002 273.00 EA __________________ __________________ Lenalidomide 25MG CAP, ORAL Contract Period: Base POP Begin: 02-06-2026 POP End: 02-05-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals
Who won similar work
24 award notices on SAM.gov in the last 24 months. Match: Same office, same NAICS 325412.
| Winner | Awards | Value | Last |
|---|---|---|---|
| CARDINAL HEALTH 414, LLC · $CAH | 10 | $17.1M | Oct 2, 2026 |
| EXELAN PHARMACEUTICALS INC | 8 | $14.3M | Feb 12, 2026 |
| JUBILANT DRAXIMAGE RADIOPHARMACIES, INC. | 3 | $1.7M | Jan 17, 2025 |
| Novartis Pharmaceuticals Corporation | 1 | $2.0M | Jan 6, 2026 |
| PETNET SOLUTIONS, INC. | 1 | $568K | Apr 14, 2025 |
| PROGENICS PHARMACEUTICALS INC | 1 | $433K | Nov 12, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Oct 2, 2026CARDINAL HEALTH 414, LLC$4.6M6505--Lab Supplies | Radiopharm | New 5 year consolidation Lebanon & Pittsburgh - Illuccix | 595 and 646 | EDA: 10/01/2026 VLD | Status: moved to collaboration, once actionable will be assigned to Chr
- Oct 1, 2026CARDINAL HEALTH 414, LLC$638K6505--Fluorodeoxyglucose (FDG) Radiopharmaceutical
- Sep 2, 2026CARDINAL HEALTH 414, LLC$3.6M6505--Lab Supplies | Radiopharm | 5-Year Indefinite Delivery/Indefinite Quantity (IDIQ) | VA Pittsburgh Healthcare System
- Jul 25, 2026CARDINAL HEALTH 414, LLC$3.6M6505--Lab Supplies | Radiopharm | 5-Year Indefinite Delivery/Indefinite Quantity (IDIQ) | VA Pittsburgh Healthcare System
- Apr 2, 2026CARDINAL HEALTH 414, LLC$2.7M6505--Intent to Sole Source | Xofigo RA-223 | Brand Name Only 5 YR-Indefinite Delivery/Indefinite Quantity (IDIQ) Multiple Stations (646, 642, 595)
- Feb 12, 2026EXELAN PHARMACEUTICALS INC$2.0M6505--Specialty Pharmaceutical Lenalidomide FAR Part 8 FSS - LPTA
- Feb 12, 2026EXELAN PHARMACEUTICALS INC$1.5M6505--Specialty Pharmaceutical Lenalidomide FAR Part 8 FSS - LPTA
- Feb 12, 2026EXELAN PHARMACEUTICALS INC$1.0M6505--Specialty Pharmaceutical Lenalidomide FAR Part 8 FSS - LPTA
- Feb 12, 2026EXELAN PHARMACEUTICALS INC$3.4M6505--Specialty Pharmaceutical Lenalidomide FAR Part 8 FSS - LPTA
- Feb 12, 2026EXELAN PHARMACEUTICALS INC$127K6505--Specialty Pharmaceutical Lenalidomide FAR Part 8 FSS - LPTA
Competitive landscape
For the 6 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $45K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 1 of the past winners are listed companies
- 0 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.